Ellen M. Apperloo
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Treatment and Management 9
- Diabetes Management and Research 1
-
- Pharmacology and Obesity Treatment 3
- Co-authors
- Hiddo Lambers Heerspink (9 shared papers)David Z.I. Cherney (5 shared papers)Kristian Kandler (1 shared paper)Rasmus Sørrig (1 shared paper)JACK P. LAWSON (1 shared paper)Dror Dicker (1 shared paper)Niels Zeuthen (1 shared paper)Melanie J. Davies (1 shared paper)
- Journals
- Diabetes Care (3 papers)Diabetes Obesity and Metabolism (2 papers)Nephrology Dialysis Transplantation (2 papers)Nature Medicine (1 paper)Journal of the American College of Cardiology (1 paper)
- Partner nations
- NetherlandsCanadaAustralia
In The Last Decade
Ellen M. Apperloo
10 papers receiving 332 citations
Ellen M. Apperloo's Hit Papers
Peers
Comparison fields: 5 of 37
- Endocrinology, Diabetes and Metabolism 222
- Nephrology 51
- Pharmacology 44
- Cardiology and Cardiovascular Medicine 25
- Transplantation 3
Countries citing papers authored by Ellen M. Apperloo
This map shows the geographic impact of Ellen M. Apperloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen M. Apperloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen M. Apperloo more than expected).
Fields of papers citing papers by Ellen M. Apperloo
This network shows the impact of papers produced by Ellen M. Apperloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen M. Apperloo. The network helps show where Ellen M. Apperloo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ellen M. Apperloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials Hit paper breakdown → | 2024 | 101 |
| 2 | 2023 | 78 | |
| 3 | Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial Hit paper breakdown → | 2024 | 76 |
| 4 | Tirzepatide Associated With Reduced Albuminuria in Participants With Type 2 Diabetes: Pooled Post Hoc Analysis From the Randomized Active- and Placebo-Controlled SURPASS-1–5 Clinical Trials Hit paper breakdown → | 2025 | 34 |
| 5 | 2023 | 28 | |
| 6 | 2024 | 13 | |
| 7 | 2018 | 7 | |
| 8 | 2025 | 3 | |
| 9 | 2025 | 3 | |
| 10 | 2024 | 1 | |
| 11 | 2024 | 0 |
About Ellen M. Apperloo
Ellen M. Apperloo is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Cardiology and Cardiovascular Medicine, Molecular Biology and Insect Science, having authored 11 papers that have together received 344 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Pharmacology and Obesity Treatment (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Blood Pressure and Hypertension Studies (2 papers) and Diabetes Management and Research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (222 citations), Nephrology (51 citations), Pharmacology (44 citations), Cardiology and Cardiovascular Medicine (25 citations) and Transplantation (3 citations). Ellen M. Apperloo has collaborated with scholars based in Netherlands, Canada and Australia. Frequent co-authors include Hiddo Lambers Heerspink, David Z.I. Cherney, Kristian Kandler, Rasmus Sørrig, JACK P. LAWSON, Dror Dicker, Niels Zeuthen, Melanie J. Davies, Julio Rosenstock and Niels Jongs. Their work appears in journals such as Diabetes Care, Diabetes Obesity and Metabolism, Nephrology Dialysis Transplantation, Nature Medicine and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.